These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of hyperuricemia and gout in CKD. Gaffo AL; Saag KG Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014 [No Abstract] [Full Text] [Related]
3. Clinical, humanistic, and economic outcomes of gout. Brixner DI; Ho MJ Am J Manag Care; 2005 Nov; 11(15 Suppl):S459-64; quiz S465-8. PubMed ID: 16300460 [TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and diagnosis of gout. Perez-Ruiz F; Castillo E; Chinchilla SP; Herrero-Beites AM Rheum Dis Clin North Am; 2014 May; 40(2):193-206. PubMed ID: 24703343 [TBL] [Abstract][Full Text] [Related]
5. Update on the management of hyperuricemia and gout. Pillinger MH; Keenan RT Bull NYU Hosp Jt Dis; 2008; 66(3):231-9. PubMed ID: 18937638 [TBL] [Abstract][Full Text] [Related]
6. Gout: an update. Eggebeen AT Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with recurrent hospital admissions for gout: a case-control study. Hutton I; Gamble G; Gow P; Dalbeth N J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730 [TBL] [Abstract][Full Text] [Related]
8. Gout: what primary care physicians want to know. Dore RK J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S47-54. PubMed ID: 18830091 [TBL] [Abstract][Full Text] [Related]
9. Gout in renal allograft recipients according to the pretransplant hyperuricemic status. Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887 [TBL] [Abstract][Full Text] [Related]
10. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Sherman MR; Saifer MG; Perez-Ruiz F Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865 [TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia and gout: new insights into pathogenesis and treatment. Pillinger MH; Rosenthal P; Abeles AM Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673 [TBL] [Abstract][Full Text] [Related]
12. [Epidemiology of hyperuricemia]. Tomita M; Murayama T; Mizuno S Nihon Rinsho; 2003 Jan; 61 Suppl 1():178-83. PubMed ID: 12629714 [No Abstract] [Full Text] [Related]
13. The changing epidemiology of gout. Roddy E; Zhang W; Doherty M Nat Clin Pract Rheumatol; 2007 Aug; 3(8):443-9. PubMed ID: 17664951 [TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia, gout and the metabolic syndrome. Puig JG; Martínez MA Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749 [TBL] [Abstract][Full Text] [Related]
16. Gout and related morbid conditions: pharmacological and SPA therapy. Petraccia L; Fraioli A; Liberati G; Lopalco M; Grassi M Minerva Med; 2008 Apr; 99(2):203-12. PubMed ID: 18431328 [TBL] [Abstract][Full Text] [Related]
17. Early onset of hyperuricaemia and gout following treatment for female to male gender reassignment. Pui K; Waddell C; Dalbeth N Rheumatology (Oxford); 2008 Dec; 47(12):1840-1. PubMed ID: 18854344 [No Abstract] [Full Text] [Related]
18. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. Malik A; Schumacher HR; Dinnella JE; Clayburne GM J Clin Rheumatol; 2009 Feb; 15(1):22-4. PubMed ID: 19125136 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847 [TBL] [Abstract][Full Text] [Related]